Coya Therapeutics, Inc. (NASDAQ:COYA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dov Goldstein Other companies: BioAge Labs, Inc. (Chief Financial Officer · Since at least Sep 25, 2024); Gain Therapeutics, Inc. (Independent Member · Since at least Mar 17, 2021); NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); Loxo Oncology Inc (CFO and Treasurer · Jul 31, 2014 – Apr 1, 2015 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jun 6, 2018 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – Jul 24, 2012 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 28, 2020 · Past); Cempra Inc (Director · Feb 2, 2012 – Mar 7, 2017 · Past) | Director · Since at least Dec 28, 2022 |
| Wilbur L Ross Jr Other companies: Taronis Fuels Inc (Director · Jun 4, 2021 – Jun 4, 2021 · Past); Ross Acquisition II Corp (Chief Executive Officer, Director · Mar 11, 2021 – Mar 11, 2021 · Past) | Director · Since at least Dec 19, 2023 |
| David Snyder Other companies: Exicure, Inc. (Chief Financial Officer · Mar 12, 2020 – Mar 12, 2020 · Past) | Chief Financial Officer & Chief Operating Officer · Since at least Dec 28, 2022 |
| Dieter Weinand Other companies: Replimune Group, Inc. (Director · Since at least Jul 19, 2018) | Chairman of the Board of Directors · Since at least Aug 18, 2023 |
| Hideki Garren Other companies: Prothena Corporation plc (Chief Medical Officer · Apr 5, 2021 – Feb 27, 2024 · Past) | Director · Dec 28, 2022 – Jan 1, 2024 · Past |
| Howard Berman Other companies: Atea Pharmaceuticals, Inc. (Director · Since at least Apr 17, 2025) | Executive Chairman, Director · Since at least Dec 28, 2022 |
| Adrian Hepner | Chief Medical Officer · Dec 28, 2022 – Feb 27, 2023 · Past |
| Anabella Villalobos | Director · Since at least Dec 28, 2022 |
| Ann Lee | Director · Since at least Jan 3, 2022 |
| Arun Swaminathan | Chief Executive Officer, Director · Since at least Aug 19, 2024 |
| Daniel Barvin | Vice President of Operations & Patient Advocacy · Since at least Nov 4, 2026 |
| Fred Grossman | Chief Medical Officer · Since at least Jul 17, 2023 |
| Fred Grossman | President & Chief Medical Officer · Since at least Oct 28, 2026 |
| Karen King | Senior VP of Program Management & Clinical Operations · Since at least Oct 28, 2026 |
| Mark Pavao | Director · Since at least Apr 1, 2026 |
| Michelle Frazier | Senior VP of Regulatory · Since at least Nov 4, 2026 |
| Wilbur Ross | Director · Since at least Nov 4, 2026 |